Oxon, United Kingdom

Alfred R Green

This inventor holds 2 USPTO granted patents. Top assignee: Aktiebolaget Astra. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alfred R Green. Retrieved from https://idiyas.com/inventor/alfred-r-green

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 1


Location History:

  • Oxon, GB (1995)
  • Southmoor, GB (1995)

Company Filing History:


Years Active: 1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Alfred R. Green: Innovator in Neurodegeneration Treatment

Introduction

Alfred R. Green is a notable inventor based in Oxon, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegeneration. With a total of 2 patents to his name, Green's work has the potential to impact many lives.

Latest Patents

Green's latest patents include innovative formulations aimed at addressing neurodegenerative conditions. One of his patents focuses on Chlormethiazole in the treatment of neurodegeneration, disclosing a thiazole formula designed to aid in the preservation of neuronal structure. Another patent presents new pharmaceutical formulations that comprise 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole or its optical isomers, along with pharmaceutically acceptable salts or solvates.

Career Highlights

Alfred R. Green is associated with Aktiebolaget Astra, a company known for its advancements in pharmaceutical research and development. His work at the company has allowed him to explore innovative solutions for complex medical challenges.

Collaborations

Throughout his career, Green has collaborated with esteemed colleagues such as Alan John Cross and Bernard R. Boar. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Alfred R. Green's contributions to the field of neurodegeneration treatment through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for future innovations in pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…